… them. By helping to streamline the flow of participants into clinical research, Fox Trial Finder is helping to speed new …

… against LRRK2 that, if successful, could be developed into breakthrough PD treatments. However, a major roadblock in LRRK2 research is the lack of quality antibodies. Antibodies are … and will provide feedback directly to MJFF. Relevance to Diagnosis/Treatment of Parkinson’s Disease: The availability …

… Since 2005, The Michael J. Fox Foundation for Parkinson's Research (MJFF) has invested significant funding and non-funding effort to accelerate research and drug development activity around the Parkinson … barriers to LRRK2 research and helped move the field into clinical trials. …

… and questions as an individual comes to terms with a diagnosis. This year alone, it’s estimated that more than … many may be navigating their Parkinson’s disease (PD) diagnosis as the world copes with an extraordinary global … spoken candidly about how he has come to terms with his own diagnosis:  “My first thought was, ‘what the hell happened …

… for Webinar Finding Your Way: Working through Emotions in Early Years with Parkinson’s First Name   Last Name   Email … has PD Extended family member or friend had PD I am a researcher, clinician or work with the PD community Other   Diagnosis Date ${selected} Jan Feb Mar Apr May Jun Jul Aug …

… of a cure. Because PPMI is an observational study, its research volunteers do not take any experimental drug or … library. This expansion is imperative to accelerate earlier diagnosis and ground-breaking treatments that may benefit … findings on, for example, brain imaging of dopamine loss in early PD and genetic variants associated with Parkinson’s. …